167 related articles for article (PubMed ID: 34503160)
1. A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells.
Castro J; Tornillo G; Ceada G; Ramos-Neble B; Bravo M; Ribó M; Vilanova M; Smalley MJ; Benito A
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503160
[TBL] [Abstract][Full Text] [Related]
2. The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27
García-Galindo G; Castro J; Matés J; Bravo M; Ribó M; Vilanova M; Benito A
Molecules; 2021 Mar; 26(5):. PubMed ID: 33801209
[TBL] [Abstract][Full Text] [Related]
3. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies.
Wang H; Cui G; Yu B; Sun M; Yang H
Curr Pharm Des; 2020; 26(17):1979-1993. PubMed ID: 32268862
[TBL] [Abstract][Full Text] [Related]
6. Increased cancer stem cell invasion is mediated by myosin IIB and nuclear translocation.
Thomas D; Thiagarajan PS; Rai V; Reizes O; Lathia J; Egelhoff T
Oncotarget; 2016 Jul; 7(30):47586-47592. PubMed ID: 27285763
[TBL] [Abstract][Full Text] [Related]
7. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
[TBL] [Abstract][Full Text] [Related]
8. Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.
Patel NJ; Sharon C; Baranwal S; Boothello RS; Desai UR; Patel BB
Oncotarget; 2016 Dec; 7(51):84608-84622. PubMed ID: 27705927
[TBL] [Abstract][Full Text] [Related]
9. Therapies targeting cancer stem cells: Current trends and future challenges.
Dragu DL; Necula LG; Bleotu C; Diaconu CC; Chivu-Economescu M
World J Stem Cells; 2015 Oct; 7(9):1185-201. PubMed ID: 26516409
[TBL] [Abstract][Full Text] [Related]
10. Generation of new cytotoxic human ribonuclease variants directed to the nucleus.
Vert A; Castro J; Ruiz-Martínez S; Tubert P; Escribano D; Ribó M; Vilanova M; Benito A
Mol Pharm; 2012 Oct; 9(10):2894-902. PubMed ID: 22957849
[TBL] [Abstract][Full Text] [Related]
11. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
[No Abstract] [Full Text] [Related]
13. Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.
Zakaria N; Mohd Yusoff N; Zakaria Z; Widera D; Yahaya BH
Front Oncol; 2018; 8():166. PubMed ID: 29868483
[TBL] [Abstract][Full Text] [Related]
14. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Mashima T
Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
De Angelis ML; Francescangeli F; Zeuner A
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells: progress and challenges in lung cancer.
Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.
López-Mateo I; Alonso-Merino E; Suarez-Cabrera C; Park JW; Cheng SY; Alemany S; Paramio JM; Aranda A
Thyroid; 2020 Jan; 30(1):116-132. PubMed ID: 31760908
[No Abstract] [Full Text] [Related]
19. Cancer cells stemness: A doorstep to targeted therapy.
Prasad S; Ramachandran S; Gupta N; Kaushik I; Srivastava SK
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165424. PubMed ID: 30818002
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways.
Doan P; Musa A; Murugesan A; Sipilä V; Candeias NR; Emmert-Streib F; Ruusuvuori P; Granberg K; Yli-Harja O; Kandhavelu M
Cells; 2020 Mar; 9(3):. PubMed ID: 32164385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
